Qing Xi

1.5k total citations · 1 hit paper
33 papers, 1.0k citations indexed

About

Qing Xi is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Qing Xi has authored 33 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Cancer Research and 8 papers in Immunology. Recurrent topics in Qing Xi's work include MicroRNA in disease regulation (4 papers), Oral microbiology and periodontitis research (4 papers) and Cancer-related molecular mechanisms research (4 papers). Qing Xi is often cited by papers focused on MicroRNA in disease regulation (4 papers), Oral microbiology and periodontitis research (4 papers) and Cancer-related molecular mechanisms research (4 papers). Qing Xi collaborates with scholars based in China, United States and Hong Kong. Qing Xi's co-authors include Rongxin Zhang, Zhenyi Xue, Jieyou Zhang, Yurong Da, Zimu Zhang, Hongkun Liu, X. Edward Guo, Guangze Yang, Zhi Yao and Lijuan Zhang and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Qing Xi

31 papers receiving 1.0k citations

Hit Papers

Immune checkpoint inhibitors: breakthroughs in cancer tre... 2024 2026 2025 2024 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qing Xi China 17 546 321 311 217 117 33 1.0k
Haimeng Yan China 12 541 1.0× 230 0.7× 314 1.0× 183 0.8× 92 0.8× 25 944
Shengping Huang United States 17 585 1.1× 218 0.7× 255 0.8× 262 1.2× 133 1.1× 31 1.2k
Yangjing Zhao China 15 456 0.8× 286 0.9× 442 1.4× 272 1.3× 125 1.1× 40 1.1k
Hsiao‐Chi Tsai Taiwan 19 564 1.0× 246 0.8× 187 0.6× 275 1.3× 96 0.8× 31 1.0k
Qifeng He China 14 490 0.9× 302 0.9× 368 1.2× 328 1.5× 105 0.9× 23 942
Xiaolan Su China 19 491 0.9× 221 0.7× 192 0.6× 218 1.0× 78 0.7× 44 916
Miranda B. Bennink Netherlands 20 649 1.2× 351 1.1× 359 1.2× 258 1.2× 53 0.5× 29 1.3k
Mathieu Derouet Canada 15 609 1.1× 204 0.6× 451 1.5× 303 1.4× 96 0.8× 24 1.1k

Countries citing papers authored by Qing Xi

Since Specialization
Citations

This map shows the geographic impact of Qing Xi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing Xi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing Xi more than expected).

Fields of papers citing papers by Qing Xi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qing Xi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing Xi. The network helps show where Qing Xi may publish in the future.

Co-authorship network of co-authors of Qing Xi

This figure shows the co-authorship network connecting the top 25 collaborators of Qing Xi. A scholar is included among the top collaborators of Qing Xi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qing Xi. Qing Xi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Jinyi, Boyan Zhou, Zhilin Li, et al.. (2025). Metabolic reprogramming of drug resistance in pancreatic cancer: mechanisms and effects. Molecular Aspects of Medicine. 103. 101368–101368. 1 indexed citations
2.
Xi, Qing, et al.. (2025). Methods for monitoring carbon emissions from ships: A practical perspective. Environmental Development. 55. 101192–101192. 3 indexed citations
3.
Xi, Qing, et al.. (2024). Quercetin Limits Tumor Immune Escape through PDK1/CD47 Axis in Melanoma. The American Journal of Chinese Medicine. 52(2). 541–563. 4 indexed citations
4.
Zhang, Jinyi, et al.. (2024). Immune checkpoint inhibitors: breakthroughs in cancer treatment. Cancer Biology and Medicine. 21(6). 1–11. 61 indexed citations breakdown →
5.
Sun, Daxiao, Yanchang Li, Shiyu Liu, et al.. (2023). Local membrane source gathering by p62 body drives autophagosome formation. Nature Communications. 14(1). 7338–7338. 25 indexed citations
6.
Zhang, Lijuan, Kai Zhang, Jieyou Zhang, et al.. (2021). Loss of fragile site-associated tumor suppressor promotes antitumor immunity via macrophage polarization. Nature Communications. 12(1). 4300–4300. 30 indexed citations
7.
Liu, Dongming, Yi Luo, Lu Chen, et al.. (2021). Diagnostic value of 5 serum biomarkers for hepatocellular carcinoma with different epidemiological backgrounds: A large-scale, retrospective study. Cancer Biology and Medicine. 18(1). 256–270. 15 indexed citations
8.
Chen, Ying, Xin Li, Dongmei Zhou, et al.. (2020). Arctigenin protects mice from thioglycollate‐induced acute peritonitis. Pharmacology Research & Perspectives. 8(5). e00660–e00660. 6 indexed citations
9.
Xi, Qing, Jieyou Zhang, Guangze Yang, et al.. (2020). Restoration of miR-340 controls pancreatic cancer cell CD47 expression to promote macrophage phagocytosis and enhance antitumor immunity. Journal for ImmunoTherapy of Cancer. 8(1). e000253–e000253. 50 indexed citations
10.
Xi, Qing, Ying Chen, Guangze Yang, et al.. (2020). miR-128 Regulates Tumor Cell CD47 Expression and Promotes Anti-tumor Immunity in Pancreatic Cancer. Frontiers in Immunology. 11. 890–890. 42 indexed citations
11.
Ren, Yinghui, X. Edward Guo, Jieyou Zhang, et al.. (2019). Parthenolide regulates oxidative stress‐induced mitophagy and suppresses apoptosis through p53 signaling pathway in C2C12 myoblasts. Journal of Cellular Biochemistry. 120(9). 15695–15708. 28 indexed citations
12.
Xue, Zhenyi, Qing Xi, Hongkun Liu, et al.. (2019). miR-21 promotes NLRP3 inflammasome activation to mediate pyroptosis and endotoxic shock. Cell Death and Disease. 10(6). 461–461. 116 indexed citations
13.
14.
Jia, Long, Qing Xi, Huafeng Wang, et al.. (2017). miR-142-5p regulates tumor cell PD-L1 expression and enhances anti-tumor immunity. Biochemical and Biophysical Research Communications. 488(2). 425–431. 142 indexed citations
15.
Cui, Wei, Jiaojiao Liu, Shuai Hou, et al.. (2016). Identification of ssDNA aptamers specific to clinical isolates of <italic>Streptococcus mutans</italic> strains with different cariogenicity. Acta Biochimica et Biophysica Sinica. 48(6). 563–572. 13 indexed citations
16.
Zuo, Duo, Liwei Chen, Xiaoqian Liu, et al.. (2015). Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma. Tumor Biology. 37(5). 6539–6549. 41 indexed citations
17.
Mijares, Dindo Q., et al.. (2012). Oral bone loss induced by mineral deficiency in a rat model: Effect of a synthetic bone mineral (SBM) preparation. Archives of Oral Biology. 57(9). 1264–1273. 17 indexed citations
18.
Xi, Qing, et al.. (2011). Immunophenotype and increased presence of CD4+CD25+ regulatory T cells in patients with acute lymphoblastic leukemia. Oncology Letters. 3(2). 421–424. 47 indexed citations
19.
Cao, Gang, Tianqiu Mao, Qing Xi, & Fulin Chen. (2002). Biological characteristics of human bone marrow stromal stem cell cultured in vitro. Di-Si Junyi Daxue xuebao. 23(3). 207–209. 1 indexed citations
20.
Du, Jianbin, Monika J. Stankiewicz, Yang Liu, et al.. (2002). Novel Combinatorial Interactions of GATA-1, PU.1, and C/EBPε Isoforms Regulate Transcription of the Gene Encoding Eosinophil Granule Major Basic Protein. Journal of Biological Chemistry. 277(45). 43481–43494. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026